The Perelman School of Medicine at the University of Pennsylvania established ASPE, the Autism Spectrum Program of Excellence, in 2017 to significantly improve the understanding of the genetic causes of Autism Spectrum Disorder (ASD) in order to energize the research and clinical community across the globe. The ASPE program was made possible by a generous donation from an anonymous philanthropist.
Genetic studies of ASD will give us greater insight into the genetic roots of the entire autism spectrum. A major focus of ASPE will be on the NRXN1 gene, which codes for the protein neurexin 1 and has been associated with autism spectrum disorder and other psychiatric and neurodevelopmental disorders.
Penn Study Points to High Priority Genes as Potential Research Targets in Autistic Spectrum Disorder
A study of a new mouse model identifies a drug target that has the potential...
“Our objective is to conduct a recurring 5K to raise awareness for our foundation, to be able to advocate for children with impairing conditions, and recruit sponsors to aid in furthering research as related to chromosomal deletions (including 2p16.3 deletions) and abnormalities which impair a child’s ability for self-independence.”
https://braelynaubreyfoundation.squarespace.com/race-sponsors
